DK516288A - Stabilisering af terapeutisk aktive proteiner i farmaceutiske praeparater - Google Patents

Stabilisering af terapeutisk aktive proteiner i farmaceutiske praeparater

Info

Publication number
DK516288A
DK516288A DK516288A DK516288A DK516288A DK 516288 A DK516288 A DK 516288A DK 516288 A DK516288 A DK 516288A DK 516288 A DK516288 A DK 516288A DK 516288 A DK516288 A DK 516288A
Authority
DK
Denmark
Prior art keywords
pharmaceutical preparations
stabilization
active proteins
therapeutic active
proteins
Prior art date
Application number
DK516288A
Other languages
Danish (da)
English (en)
Other versions
DK516288D0 (da
Inventor
Traute Mundorf
Kurt Schnecker
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of DK516288D0 publication Critical patent/DK516288D0/da
Publication of DK516288A publication Critical patent/DK516288A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK516288A 1987-09-17 1988-09-16 Stabilisering af terapeutisk aktive proteiner i farmaceutiske praeparater DK516288A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873731255 DE3731255A1 (de) 1987-09-17 1987-09-17 Stabilisierung von therapeutisch wirksamen proteinen in pharmazeutischen zubereitungen

Publications (2)

Publication Number Publication Date
DK516288D0 DK516288D0 (da) 1988-09-16
DK516288A true DK516288A (da) 1989-03-18

Family

ID=6336244

Family Applications (1)

Application Number Title Priority Date Filing Date
DK516288A DK516288A (da) 1987-09-17 1988-09-16 Stabilisering af terapeutisk aktive proteiner i farmaceutiske praeparater

Country Status (20)

Country Link
EP (1) EP0307857B1 (ru)
JP (1) JP2783552B2 (ru)
KR (1) KR970008112B1 (ru)
AT (1) ATE126063T1 (ru)
AU (1) AU615473B2 (ru)
CA (1) CA1329121C (ru)
DD (1) DD274562A5 (ru)
DE (2) DE3731255A1 (ru)
DK (1) DK516288A (ru)
ES (1) ES2077559T3 (ru)
FI (1) FI95770C (ru)
GR (1) GR3017432T3 (ru)
HU (1) HU203045B (ru)
IE (1) IE70908B1 (ru)
IL (1) IL87778A (ru)
NO (1) NO179436C (ru)
NZ (1) NZ226209A (ru)
PT (1) PT88539B (ru)
RU (1) RU2093145C1 (ru)
ZA (1) ZA886903B (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5332577A (en) * 1988-12-27 1994-07-26 Dermamed Transdermal administration to humans and animals
US5241925A (en) * 1988-12-27 1993-09-07 Dermamed Apparatus and techniques for administering veterinary medicaments
US5130298A (en) * 1989-05-16 1992-07-14 Ethicon, Inc. Stabilized compositions containing epidermal growth factor
US5324521A (en) * 1989-12-18 1994-06-28 Dermamed Systems for transdermal administration of medicaments
JPH0776527A (ja) * 1993-06-28 1995-03-20 Hayashibara Biochem Lab Inc 半固形製剤とその製造方法
ITMI20031640A1 (it) * 2003-08-08 2005-02-09 Mipharm S P A Base per gel bioadesivi.
CU23432B6 (es) * 2005-11-02 2009-10-16 Ct Ingenieria Genetica Biotech Formulaciones estabilizadas que contienen a los interferones gamma y alfa en proporciones potenciadoras
WO2011138155A1 (en) 2010-05-04 2011-11-10 Viscogel Ab Chitosan composition
DK3638251T3 (da) * 2017-06-12 2024-05-13 Lakewood Amedex Inc Bisphosphocin gel formuleringer og brug deraf

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5413223A (en) * 1977-07-01 1979-01-31 Ricoh Co Ltd Printer unit
GB2016015B (en) * 1978-01-22 1982-05-06 Hayashibara Co Method of preparing interferon and preparations containing interferon
JPS5598118A (en) * 1979-01-18 1980-07-25 Hayashibara Takeshi Preparation of type-2 interferon and drug containing the same
SE8204382L (sv) * 1981-07-21 1983-01-22 Hayashibara Biochem Lab Sett att framstella malcellysfaktor och anvendning derav
CA1190148A (en) * 1981-10-13 1985-07-09 Samuel S. Asculai Interferon-containing compositions
JPS5892622A (ja) * 1981-11-28 1983-06-02 Sunstar Inc インタ−フエロン安定配合製剤
US4659696A (en) * 1982-04-30 1987-04-21 Takeda Chemical Industries, Ltd. Pharmaceutical composition and its nasal or vaginal use
JPS5910524A (ja) * 1982-07-08 1984-01-20 Toray Ind Inc インタ−フエロン組成物およびその製造法
JPS6061535A (ja) * 1983-08-24 1985-04-09 エフ・ホフマン・ラ・ロシユ・ウント・コンパニ−・アクチエンゲゼルシヤフト 製薬学的組成物
EP0177342A3 (en) * 1984-10-04 1987-12-02 Genentech, Inc. Oral formulation of therapeutic proteins
DE3603444A1 (de) * 1986-02-05 1987-08-06 Thomae Gmbh Dr K Pharmazeutische zubereitungsformen zur stabilisierung von interferon alpha
US4822605A (en) * 1986-02-18 1989-04-18 Exovir, Inc. Compositions and methods employing the same for the treatment of viral and cancerous skin lesions and the like

Also Published As

Publication number Publication date
IE882812L (en) 1989-03-17
NO884123L (no) 1989-03-20
NZ226209A (en) 1991-06-25
HUT47436A (en) 1989-03-28
DD274562A5 (de) 1989-12-27
PT88539A (pt) 1988-10-01
DE3731255A1 (de) 1989-04-06
ZA886903B (en) 1990-05-30
NO884123D0 (no) 1988-09-16
JP2783552B2 (ja) 1998-08-06
AU2231688A (en) 1989-03-23
NO179436C (no) 1996-10-09
JPH01102029A (ja) 1989-04-19
DE3854290D1 (de) 1995-09-14
IL87778A0 (en) 1989-03-31
RU2093145C1 (ru) 1997-10-20
EP0307857A1 (de) 1989-03-22
GR3017432T3 (en) 1995-12-31
EP0307857B1 (de) 1995-08-09
FI884240A (fi) 1989-03-18
FI884240A0 (fi) 1988-09-15
KR890004719A (ko) 1989-05-09
ES2077559T3 (es) 1995-12-01
ATE126063T1 (de) 1995-08-15
DK516288D0 (da) 1988-09-16
NO179436B (no) 1996-07-01
CA1329121C (en) 1994-05-03
FI95770C (fi) 1996-03-25
AU615473B2 (en) 1991-10-03
IL87778A (en) 1993-05-13
HU203045B (en) 1991-05-28
IE70908B1 (en) 1997-01-15
PT88539B (pt) 1992-11-30
KR970008112B1 (ko) 1997-05-21
FI95770B (fi) 1995-12-15

Similar Documents

Publication Publication Date Title
ATE91903T1 (de) Pharmazeutische kombinationspraeparate und deren verwendung als antineoplastische arzneimittel.
DK653688A (da) Stabiliserede laegemiddelaktive forbindelser, fremgangsmaade til deres frmstilling samt stabile laegemiddelpraeparater
FI875533A (fi) Insulinpreparat foer non-parenteral dosering.
DK203787A (da) Praeparat til nasal administrering
ZA885192B (en) Pharmaceutical preparations
PT97160A (pt) Processo para a preparacao de composicoes estaveis para administracao parenterica contendo uma proteina, peptideo ou polipeptideo biologicamente activo
FI862011A (fi) Terapeutiska nukleosider.
DE3770280D1 (de) Pharmazeutische zubereitungsformen zur stabilisierung von interferon alpha.
DE3769707D1 (de) Therapeutisches system mit geregelter wirkstoffabgabe.
ATE56138T1 (de) Perfluorkohlenwasserstoffe als vehikel zur verabreichung von arzneimitteln.
DK516288A (da) Stabilisering af terapeutisk aktive proteiner i farmaceutiske praeparater
DK0458588T3 (da) Behandling af okulær hypertension med en synergistisk kombination til okulær administration
ATE38151T1 (de) Bestaendige 5-adenosyl-l-methionin-salze enthaltende, pharmazeutische zusammensetzungen fuer orale anwendung.
NO810480L (no) Anologifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4-oksadiazolylfenol-derivater
NO913644D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
DE3773322D1 (de) Pharmazeutische zubereitungen mit heilender aktivitaet.

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment